All Online

1 - 7 of 7 results

Refine

Active filters

Alzheimer Disease
Doctor talking to elderly patient with a caregiver present
0.53 CME CREDIT

Early Detection and Diagnosis of Alzheimer Disease

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.53 AANP

In this AdaptED learning module, learners will engage with the adaptive learning algorithm to explore the assessment and diagnosis of Alzheimer disease (AD). The activity will provide practical guidance for primary care providers on the clinical diagnosis of AD, including cognitive testing. It will also discuss neuroimaging and fluid markers to aid in diagnosis and monitoring of AD, including ongoing research in serum biomarkers that may soon expedite disease recognition. The AdaptED module will provide learners with evidence-based education in a convenient format that facilitates quick application of the material.


Clinician talking to elderly person
0.3 CME CREDIT

Despite the growing prevalence and devastating effects of Alzheimer disease (AD), mild cognitive impairment (MCI) often goes unrecognized in the primary care setting. This brief podcast highlights the need for primary care providers to identify individuals with MCI as early as possible so they can be assessed and, if diagnosed with AD, treated promptly. Expert faculty will explore the manifold benefits of early evaluation, which can include identifying reversible causes of MCI, taking advantage of new effective treatments, and reducing patients’ risk of premature mortality. You’ll walk away from this podcast with strategies to help you earlier identify these patients and, ultimately, maintain their cognitive abilities and quality of life for a longer period.


modern abstract brain image
0.5 CME CREDIT

New and Emerging Therapies for Alzheimer Disease

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.50 Pharmacology


Tile overview image
0.25 CME CREDIT

This short podcast will focus on new and emerging monoclonal antibody therapies targeting β-amyloid, with a focus on the importance of early recognition and diagnosis of Alzheimer disease to allow prompt treatment for patients in the early stages of the disease who may derive the most benefit from these agents.


Elderly patient holding doctors hands
0.25 CME CREDIT

Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.


Elderly man with physician
0.29 CME CREDIT

Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.